#parkinson

• Akinesia — The total absence, loss, or pathological inability to execute voluntary muscular movements, while basic muscular strength is otherwise preserved; it is a severe clinical symptom structurally caused by major neurological dysfunctions within the basal ganglia, extrapyramidal pathways, or motor cortex. This phenomenon is characteristically found in advanced stages of Parkinson's disease, parkinsonian syndromes, catatonic states, or as a result of severe brain injuries, frequently manifesting in close association with muscular rigidity and bradykinesia.
• Antiparkinsonian — Combating, ameliorating, or controlling the symptoms of Parkinson's disease and extrapyramidal syndromes; a drug or therapeutic agent structurally designed to restore the balance of neurotransmitters in the brain, specifically by increasing dopamine levels or blocking the effects of acetylcholine. This precision medication reduces muscle rigidity, mitigates involuntary tremors, and significantly improves motor control.
• Apomorphine — A medicinal substance chemically derived from morphine via dehydration, yet devoid of analgesic or narcotic properties, acting as a potent and non-selective dopamine receptor agonist; a fast-acting emetic. In contemporary medical practice, it is utilized as an injection or infusion for treating acute immobility episodes ('off' periods) in advanced Parkinson's disease patients.